Selected research
Industry Growth & Trends
Global Vermox Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Vermox market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Vermox is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Vermox is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vermox is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Vermox market include Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Vermox market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vermox market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vermox market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vermox.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Vermox market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vermox Market by Company
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Johnson & Johnson
Vermox Segment by Type
Tablet
Oral Suspension
Vermox Segment by Application
Children
Adult
Vermox Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vermox market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vermox and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vermox.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Vermox companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Suspension
Applications
- Children
- Adult
Companies covered
- Amneal Pharmaceuticals
- Cadila Pharmaceuticals
- Eipico
- Esteve Pharmaceuticals
- Tenry
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Vermox Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Vermox Market Size by Region (2021-2032)
- 1.4.1 Global Vermox Market Size by Region (2021-2026)
- 1.4.2 Global Vermox Market Size by Region (2027-2032)
- 1.5 Key Regions Vermox Market Size (2021-2032)
- 1.5.1 North America Vermox Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Vermox Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Vermox Market Size Growth Rate (2021-2032)
- 1.5.4 South America Vermox Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Vermox Market Size Growth Rate (2021-2032)
2 Vermox Market by Type
- 2.1 Type Introduction
- 2.1.1 Tablet
- 2.1.2 Oral Suspension
- 2.2 Global Vermox Market Size by Type
- 2.2.1 Global Vermox Market Size Overview by Type (2021-2032)
- 2.2.2 Global Vermox Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Vermox Market Size Forecasted by Type (2027-2032)
- 2.3 Global Vermox Market Size by Regions
- 2.3.1 North America Vermox Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Vermox Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Vermox Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Vermox Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Vermox Market Size Breakdown by Type (2021-2026)
3 Vermox Market by Application
- 3.1 Type Introduction
- 3.1.1 Children
- 3.1.2 Adult
- 3.2 Global Vermox Market Size by Application
- 3.2.1 Global Vermox Market Size Overview by Application (2021-2032)
- 3.2.2 Global Vermox Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Vermox Market Size Forecasted by Application (2027-2032)
- 3.3 Global Vermox Market Size by Regions
- 3.3.1 North America Vermox Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Vermox Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Vermox Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Vermox Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Vermox Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Vermox Industry Trends
- 4.2 Vermox Industry Drivers
- 4.3 Vermox Industry Opportunities and Challenges
- 4.4 Vermox Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Vermox Revenue (2021-2026)
- 5.2 Global Vermox Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Vermox Key Company Headquarters & Area Served
- 5.4 Global Vermox Company, Product Type & Application
- 5.5 Global Vermox Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Vermox Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Vermox Players Market Share by Revenue in 2025
- 5.6.3 2025 Vermox Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Amneal Pharmaceuticals
- 6.1.1 Amneal Pharmaceuticals Company Information
- 6.1.2 Amneal Pharmaceuticals Business Overview
- 6.1.3 Amneal Pharmaceuticals Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Amneal Pharmaceuticals Vermox Product Portfolio
- 6.1.5 Amneal Pharmaceuticals Recent Developments
- 6.2 Cadila Pharmaceuticals
- 6.2.1 Cadila Pharmaceuticals Company Information
- 6.2.2 Cadila Pharmaceuticals Business Overview
- 6.2.3 Cadila Pharmaceuticals Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Cadila Pharmaceuticals Vermox Product Portfolio
- 6.2.5 Cadila Pharmaceuticals Recent Developments
- 6.3 Eipico
- 6.3.1 Eipico Company Information
- 6.3.2 Eipico Business Overview
- 6.3.3 Eipico Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eipico Vermox Product Portfolio
- 6.3.5 Eipico Recent Developments
- 6.4 Esteve Pharmaceuticals
- 6.4.1 Esteve Pharmaceuticals Company Information
- 6.4.2 Esteve Pharmaceuticals Business Overview
- 6.4.3 Esteve Pharmaceuticals Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Esteve Pharmaceuticals Vermox Product Portfolio
- 6.4.5 Esteve Pharmaceuticals Recent Developments
- 6.5 Tenry
- 6.5.1 Tenry Company Information
- 6.5.2 Tenry Business Overview
- 6.5.3 Tenry Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tenry Vermox Product Portfolio
- 6.5.5 Tenry Recent Developments
- 6.6 Johnson & Johnson
- 6.6.1 Johnson & Johnson Company Information
- 6.6.2 Johnson & Johnson Business Overview
- 6.6.3 Johnson & Johnson Vermox Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Johnson & Johnson Vermox Product Portfolio
- 6.6.5 Johnson & Johnson Recent Developments
7 North America
- 7.1 North America Vermox Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Vermox Market Size by Country (2021-2026)
- 7.3 North America Vermox Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Vermox Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Vermox Market Size by Country (2021-2026)
- 8.3 Europe Vermox Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vermox Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Vermox Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Vermox Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Vermox Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Vermox Market Size by Country (2021-2026)
- 10.3 South America Vermox Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vermox Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Vermox Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Vermox Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst